Ecuador: Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses 2024

Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Ecuador

In 2022, the Ecuadorian prophylactic medicaments containing insulin market decreased by -12.8% to $X for the first time since 2019, thus ending a two-year rising trend. In general, consumption, however, continues to indicate a significant increase. Prophylactic medicaments containing insulin consumption peaked at $X in 2021, and then declined in the following year.

Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Exports from Ecuador

In 2022, after eight years of decline, there was significant decline in overseas shipments of medicaments containing insulin but not antibiotics in measured doses, when their volume decreased by -33.3% to X kg. Overall, exports continue to indicate a sharp slump. The most prominent rate of growth was recorded in 2013 when exports increased by 79%. As a result, the exports attained the peak of X kg. From 2014 to 2022, the growth of the exports remained at a somewhat lower figure.

In value terms, prophylactic medicaments containing insulin exports skyrocketed to $X in 2022. Over the period under review, exports faced a sharp decline. Over the period under review, the exports reached the maximum at $X in 2013; however, from 2014 to 2022, the exports failed to regain momentum.

Exports by Country

Canada (X kg) and Panama (X kg) were the main destinations of prophylactic medicaments containing insulin exports from Ecuador.

From 2012 to 2022, the most notable rate of growth in terms of shipments, amongst the main countries of destination, was attained by Panama (with a CAGR of 0.0%).

In value terms, Panama ($X) emerged as the key foreign market for medicaments containing insulin but not antibiotics in measured doses exports from Ecuador, comprising 87% of total exports. The second position in the ranking was taken by Canada ($X), with a 13% share of total exports.

From 2012 to 2022, the average annual rate of growth in terms of value to Panama was relatively modest.

Export Prices by Country

In 2022, the average prophylactic medicaments containing insulin export price amounted to $X per ton, picking up by 161% against the previous year. Overall, export price indicated a notable increase from 2012 to 2022: its price increased at an average annual rate of +2.9% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. As a result, the export price reached the peak level and is likely to continue growth in the immediate term.

There were significant differences in the average prices for the major overseas markets. In 2022, amid the top suppliers, the country with the highest price was Panama ($X per ton), while the average price for exports to Canada totaled $X per ton.

From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to Canada (-9.9%).

Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Imports into Ecuador

In 2022, after two years of growth, there was significant decline in supplies from abroad of medicaments containing insulin but not antibiotics in measured doses, when their volume decreased by -7.2% to X tons. Overall, imports, however, continue to indicate a significant expansion. The pace of growth appeared the most rapid in 2014 when imports increased by 306%. Over the period under review, imports attained the peak figure at X tons in 2021, and then fell in the following year.

In value terms, prophylactic medicaments containing insulin imports reduced to $X in 2022. Over the period under review, imports, however, enjoyed a significant increase. The most prominent rate of growth was recorded in 2014 when imports increased by 304% against the previous year. Over the period under review, imports hit record highs at $X in 2016; however, from 2017 to 2022, imports remained at a lower figure.

Imports by Country

In 2022, France (X tons) constituted the largest prophylactic medicaments containing insulin supplier to Ecuador, with a 46% share of total imports. Moreover, prophylactic medicaments containing insulin imports from France exceeded the figures recorded by the second-largest supplier, Germany (X tons), twofold. The third position in this ranking was held by Denmark (X tons), with a 20% share.

From 2012 to 2022, the average annual growth rate of volume from France amounted to +79.2%. The remaining supplying countries recorded the following average annual rates of imports growth: Germany (+26.3% per year) and Denmark (+51.8% per year).

In value terms, the largest prophylactic medicaments containing insulin suppliers to Ecuador were France ($X), Germany ($X) and Denmark ($X), with a combined 90% share of total imports.

In terms of the main suppliers, France, with a CAGR of +83.7%, recorded the highest growth rate of the value of imports, over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

In 2022, the average prophylactic medicaments containing insulin import price amounted to $X per ton, declining by -7.9% against the previous year. In general, the import price showed a perceptible decline. The growth pace was the most rapid in 2021 an increase of 15%. The import price peaked at $X per ton in 2016; however, from 2017 to 2022, import prices failed to regain momentum.

There were significant differences in the average prices amongst the major supplying countries. In 2022, amid the top importers, the country with the highest price was Panama ($X per ton), while the price for Italy ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Mexico (+10.3%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :